Patick, A K <br/><br/>
Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitro.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Oct 1997 
 - 2159-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.41.10.2159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Drug Combinations<br/>HIV Infections--drug therapy<br/>HIV Protease--metabolism<br/>HIV Protease Inhibitors--pharmacology<br/>Humans<br/>Nelfinavir--pharmacology<br/>Protease Inhibitors--pharmacology<br/>Reverse Transcriptase Inhibitors--pharmacology